Montanaro Asset Management LTD Novo Cure LTD Transaction History

Montanaro Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $1.31 Million - $1.84 Million	-21,800 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $5.48 Million - $8.91 Million	-73,000 Reduced 77.0%	21,800 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $2.54 Million - $4.25 Million	-21,850 Reduced 18.73%	94,800 $11 Million
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $260,800 - $451,160	2,000 Added 1.74%	116,650 $25.9 Million
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $3.1 Million - $4.74 Million	-24,950 Reduced 17.87%	114,650 $15.2 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $15.7 Million - $24.3 Million	139,600 New	139,600 $24.2 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.07B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Montanaro Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Montanaro Asset Management LTD with notifications on news.